Literature DB >> 19031020

Dendritic cell migration to peripheral lymph nodes.

Alfonso Martín-Fontecha1, Antonio Lanzavecchia, Federica Sallusto.   

Abstract

Dendritic cells are potent antigen-presenting cells endowed with the unique ability to prime T-cell responses. To present foreign antigens to na ive T cells, dendritic cells must migrate from inflamed or injured peripheral tissues to the closest draining lymph nodes through afferent lymphatic vessels. In addition, conventional dendritic cells, plasmacytoid dendritic cells and monocytes enter lymph nodes from blood crossing high endothelial venules. The selective migration of dendritic cells and their residence in non lymphoid as well as in lymphoid organs are tightly regulated events, whose molecular control is being unraveled rapidly. In this chapter, we review key aspects of what is known about dendritic cell traffic to peripheral nodes from tissues, in particular skin, and from blood. A better understanding of the regulation of dendritic cell migration for optimal priming of T-cell responses is essential for future advances in manipulating dendritic cell traffic as a means to improve immune responses in clinical settings.

Mesh:

Substances:

Year:  2009        PMID: 19031020     DOI: 10.1007/978-3-540-71029-5_2

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  41 in total

1.  STAT3 Knockdown in B16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo.

Authors:  Aws Alshamsan; Samar Hamdy; Azita Haddadi; John Samuel; Ayman O S El-Kadi; Hasan Uludağ; Afsaneh Lavasanifar
Journal:  Transl Oncol       Date:  2011-06-01       Impact factor: 4.243

Review 2.  Tolerogenic dendritic cells and their potential applications.

Authors:  Jim Hu; Yonghong Wan
Journal:  Immunology       Date:  2011-01-05       Impact factor: 7.397

Review 3.  Dendritic cell interactions with lymphatic endothelium.

Authors:  Erica Russo; Maximilian Nitschké; Cornelia Halin
Journal:  Lymphat Res Biol       Date:  2013-09       Impact factor: 2.589

Review 4.  Directing dendritic cell immunotherapy towards successful cancer treatment.

Authors:  Rachel Lubong Sabado; Nina Bhardwaj
Journal:  Immunotherapy       Date:  2010-01       Impact factor: 4.196

5.  Decreased Interferon γ Production in CD3+ and CD3- CD56+ Lymphocyte Subsets in Metastatic Regional Lymph Nodes of Melanoma Patients.

Authors:  Ana Vuletić; Irena Jovanić; Vladimir Jurišić; Zorka Milovanović; Srđan Nikolić; Igor Spurnić; Gordana Konjević
Journal:  Pathol Oncol Res       Date:  2015-05-03       Impact factor: 3.201

Review 6.  Role of lymphatic vasculature in regional and distant metastases.

Authors:  Simona Podgrabinska; Mihaela Skobe
Journal:  Microvasc Res       Date:  2014-07-12       Impact factor: 3.514

Review 7.  Laser vaccine adjuvants. History, progress, and potential.

Authors:  Satoshi Kashiwagi; Timothy Brauns; Jeffrey Gelfand; Mark C Poznansky
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

8.  An in silico model of cytotoxic T-lymphocyte activation in the lymph node following short peptide vaccination.

Authors:  Liam V Brown; Eamonn A Gaffney; Jonathan Wagg; Mark C Coles
Journal:  J R Soc Interface       Date:  2018-03       Impact factor: 4.118

9.  Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.

Authors:  Sébastien Anguille; Evelien L J M Smits; Nathalie Cools; Herman Goossens; Zwi N Berneman; Vigor F I Van Tendeloo
Journal:  J Transl Med       Date:  2009-12-18       Impact factor: 5.531

10.  Three-day dendritic cells for vaccine development: antigen uptake, processing and presentation.

Authors:  Maja Bürdek; Stefani Spranger; Susanne Wilde; Bernhard Frankenberger; Dolores J Schendel; Christiane Geiger
Journal:  J Transl Med       Date:  2010-09-28       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.